Scarica l'app Stockscreener
2.8077
9.46%
0.2427
Dopo l'orario di chiusura:
2.81
0.0023
+0.08%
Precedente Chiudi:
$2.565
Aprire:
$2.89
Volume 24 ore:
66,452
Relative Volume:
2.41
Capitalizzazione di mercato:
$6.43M
Reddito:
$2.86M
Utile/perdita netta:
$-3.16M
Rapporto P/E:
-1.3718
EPS:
-2.0467
Flusso di cassa netto:
$-2.72M
1 W Prestazione:
+22.61%
1M Prestazione:
+29.15%
6M Prestazione:
-22.01%
1 anno Prestazione:
-17.18%
Intervallo 1D:
$2.59
$2.89
Intervallo di 1 settimana:
$2.2001
$2.89
Portata 52W:
$1.90
$13.93
Xenetic Biosciences Inc Stock (XBIO) Company Profile
Nome
Xenetic Biosciences Inc
Settore
Industria
Telefono
781-778-7720
Indirizzo
945 CONCORD ST., FRAMINGHAM, MA
Compare XBIO vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
XBIO
Xenetic Biosciences Inc
|
2.8077 | 6.43M | 2.86M | -3.16M | -2.72M | -2.0467 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.34 | 119.23B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
745.77 | 78.84B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
700.45 | 43.35B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
313.41 | 41.57B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.05 | 31.51B | 5.36B | 287.73M | 924.18M | 2.5229 |
Xenetic Biosciences Inc Stock (XBIO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2020-01-08 | Iniziato | Maxim Group | Buy |
Xenetic Biosciences Inc Borsa (XBIO) Ultime notizie
Xenetic (XBIO) Reports Increased Revenue and Advances Clinical D - GuruFocus
Xenetic Biosciences, Inc. Reports Full Year 2025 Financial Results - Bitget
[8-K] Xenetic Biosciences, Inc. Reports Material Event | XBIO SEC FilingForm 8-K - Stock Titan
Cancer biotech Xenetic grows Takeda royalties to $3M, trims costs - Stock Titan
Xenetic Biosciences: Fourth Quarter Financial Results Overview - Bitget
Xenetic Biosciences 2025 Annual Report: Advancing DNase Immuno-Oncology Technology for Solid Tumors and Strategic Business Developments - Minichart
Xenetic Biosciences: Q4 Earnings Snapshot - 10tv.com
Xenetic Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Risk On: Can Xenetic Biosciences Inc be recession proofWeekly Profit Summary & Daily Oversold Stock Bounce Ideas - baoquankhu1.vn
Big Money Moves: Is Xenetic Biosciences Inc stock a value trapJuly 2025 Retail & Community Consensus Stock Picks - baoquankhu1.vn
Published on: 2026-03-07 03:26:22 - baoquankhu1.vn
Can Xenetic Biosciences Inc be recession proofTrade Performance Summary & Fast Gain Stock Tips - baoquankhu1.vn
XBIO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Analyst Downgrade: Can Xenetic Biosciences Inc be recession proofQuarterly Investment Review & Safe Capital Allocation Plans - baoquankhu1.vn
XBIO Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Xenetic Biosciences, Inc. Reports Second Quarter 2025 Financial Results - Montgomery Advertiser
XBIO Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Xenetic Biosciences Inc. (XBIO) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
XBIO Should I Buy - Intellectia AI
Xenetic Biosciences, Inc. (NASDAQ:XBIO) Sees Large Increase in Short Interest - Defense World
Trading Recap: Is AMKR stock a value trapWeekly Loss Report & Growth Focused Stock Reports - baoquankhu1.vn
Xenetic Biosciences, Inc. Announces Adjournment of 2025 Annual Meeting - Independent Mail
Is Xenetic Biosciences Inc stock undervalued right now2025 Sector Review & Technical Buy Zone Confirmations - baoquankhu1.vn
Aug Analyst Calls: Is now the right time to enter Xenetic Biosciences IncJuly 2025 Pullbacks & Safe Entry Trade Reports - baoquankhu1.vn
Technical Analysis: Is VRMEW affected by consumer sentimentChart Signals & Growth Focused Stock Pick Reports - baoquankhu1.vn
Can Xenetic Biosciences Inc. stock deliver strong Q4 earnings2025 Retail Activity & Safe Swing Trade Setup Alerts - mfd.ru
Investor Mood: Whats the outlook for Xenetic Biosciences Incs sectorWeekly Risk Summary & Weekly Stock Breakout Alerts - baoquankhu1.vn
Trend Report: Whats the profit margin of Xenetic Biosciences Inc2025 EndofYear Setup & Community Verified Swing Trade Signals - baoquankhu1.vn
Aug PreEarnings: Can Xenetic Biosciences Inc maintain sales growthWeekly Stock Report & Growth Oriented Trade Recommendations - baoquankhu1.vn
Support Test: Is National Energy Services Reunited Corp gaining market shareMarket Growth Report & AI Driven Stock Price Forecasts - baoquankhu1.vn
Can Xenetic Biosciences Inc. be recession proofGDP Growth & Growth Focused Stock Pick Reports - mfd.ru
How cyclical is Xenetic Biosciences Inc.’s revenue streamEarnings Overview Report & Smart Money Movement Tracker - mfd.ru
Is Xenetic Biosciences Inc. stock undervalued right nowRate Cut & Real-Time Price Movement Reports - mfd.ru
Xenetic Biosciences appoints James Parslow as interim CEO - Intellectia AI
Renaissance holds 7.79% of Xenetic Biosciences (XBIO) shares - Stock Titan
Aug Drivers: Can Xenetic Biosciences Inc be recession proofTrade Performance Summary & Long-Term Safe Investment Plans - baoquankhu1.vn
Short Interest in Xenetic Biosciences, Inc. (NASDAQ:XBIO) Increases By 231.4% - Defense World
Earnings Risk: Is Xenetic Biosciences Inc stock undervalued right nowQuarterly Risk Review & AI Powered Trade Plan Recommendations - baoquankhu1.vn
Fundamentals Check: Will DGLY stock hit new highs in YEARJuly 2025 Closing Moves & Daily Oversold Bounce Ideas - baoquankhu1.vn
Xenetic Biosciences, Inc. Expands Research and Development Collaboration with The Scripps Research Institute to Advance DNase Platform - Central New Jersey News
US Market Recap: What is the long term forecast for TELO stockTrade Risk Assessment & AI Forecast Swing Trade Picks - baoquankhu1.vn
Aug Sectors: Can Xenetic Biosciences Inc be recession proof2025 Dividend Review & Real-Time Buy Signal Notifications - baoquankhu1.vn
Critical Contrast: Cumberland Pharmaceuticals (NASDAQ:CPIX) vs. Xenetic Biosciences (NASDAQ:XBIO) - Defense World
Xenetic Biosciences, Inc. Extends Research and Development Collaboration with Institute Investigator at Scripps Research to Advance DNase Platform - Visalia Times-Delta
Earnings Risk: Is Xenetic Biosciences Inc stock a value trapWeekly Trade Summary & Short-Term High Return Strategies - baoquankhu1.vn
Merger Talk: Can Xenetic Biosciences Inc maintain sales growthInsider Selling & Weekly Setup with High ROI Potential - baoquankhu1.vn
Aug Opening: Whats next for PGEN stockTrade Performance Summary & Community Verified Swing Trade Signals - baoquankhu1.vn
FOMO Trade: Does Xenetic Biosciences Inc stock reflect fundamentals2025 Winners & Losers & Safe Capital Growth Tips - baoquankhu1.vn
Take Profit: Will Xenetic Biosciences Inc stock benefit from M A2025 Winners & Losers & High Accuracy Investment Signals - baoquankhu1.vn
Activity Recap: Is Xenetic Biosciences Inc stock good for income investorsJuly 2025 Highlights & Daily Price Action Insights - baoquankhu1.vn
Recap Report: Is now the right time to enter Xenetic Biosciences IncJuly 2025 Update & Free Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Xenetic Biosciences Inc Azioni (XBIO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.48%
1.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):